Preoperative assessment for the risk of Clavien-Dindo classification ≥ II grade complications after total parathyroidectomy without auto-transplantation in patients with secondary hyperparathyroidism. [PDF]
Ni Y +7 more
europepmc +1 more source
Pharmacodynamic Modeling of Cinacalcet in Secondary Hyperparathyroidism: Efficacy and Influencing Factors Analysis. [PDF]
Wang Z +10 more
europepmc +1 more source
Vitamin D: an important treatment for secondary hyperparathyroidism in chronic kidney disease? [PDF]
Yu J, Li Y, Zhu B, Shen J, Miao L.
europepmc +1 more source
Assessment of quality of life following subtotal parathyroidectomy in patients with secondary hyperparathyroidism resulting from end-stage renal disease: a single-center prospective study in Vietnam. [PDF]
Hiep PH +12 more
europepmc +1 more source
Predictors of Hungry Bone Syndrome After Parathyroidectomy in Secondary Hyperparathyroidism: A Narrative Review of Bone Turnover Biomarkers and Risk Prediction Tools. [PDF]
Coman A +11 more
europepmc +1 more source
From Secondary Hyperparathyroidism to Neurologic Crisis: A Tale of Brown Tumor and Spinal Cord Compression. [PDF]
Kormanis A +3 more
europepmc +1 more source
Related searches:
Secondary and Tertiary Hyperparathyroidism
Journal of Clinical Densitometry, 2013We reviewed the etiology and management of secondary and tertiary hyperparathyroidism. Secondary hyperparathyroidism is characterized by an increase in parathyroid hormone (PTH) that is appropriate and in response to a stimulus, most commonly low serum calcium. In secondary hyperparathyroidism, the serum calcium is normal and the PTH level is elevated.
Sophie A Jamal
exaly +3 more sources

